SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-16-759034
Filing Date
2016-11-03
Accepted
2016-11-03 17:10:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 POS AM d282695dposam.htm POS AM 17173
  Complete submission text file 0001193125-16-759034.txt   18379
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-204710 | Film No.: 161972676
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences